2012-11-30T16:00:51-06:00 2012-03-31 ERNST & YOUNG US LLP 1901 SIXTH AVE NORTH STE 1200 BIRMINGHAM AL 35203 990 2011-04-01 751835298 SUSAN G KOMEN BREAST CANCER FOUNDATION INC % Mark Nadolny SUSA 9728551600 5005 LBJ FREEWAY DALLAS TX 752446125 MARK NADOLNY 2012-11-30 2052541608 2011 2016-02-24 21:20:13Z SUSAN G KOMEN FOR THE CURE Ambassador Nancy G Brinker 5005 LBJ FREEWAY STE 250 DALLAS TX 752446125 299790668 false 7164 X www.komen.org X 1982 TX Our mission is a world without breast cancer; to save lives by empowering people, ensuring quality care for all, and energizing science to discover and deliver the cures. 9 7 346 9500 0 174658160 159779664 34417471 33193701 6372156 7951630 -6491760 -3836540 208956027 197088455 76205302 71697843 0 0 24232513 26312020 829211 1160108 25743361 91171573 89188244 192438599 188358215 16517428 8730240 319777847 313104320 205749113 193001246 114028734 120103074 X Our Promise: To save lives and end breast cancer forever by EMPOWERING PEOPLE, ENSURING QUALITY CARE FOR ALL, AND ENERGIZING SCIENCE TO discover and deliver the cures. false false 70833312 60931021 33926771 Grants to other charitable organizations to support research and clinical investigation of breast cancer. See schedule O for additional details. 71273697 5594191 0 Public health education programs to increase the public's AWARENESS of breast cancer including, among other things, detection and treatment. See schedule O for additional details. 9482705 5172631 0 Health treatment and screening programs and grants. See schedule O for additional details. 0 0 0 151589714 true true false true false false false false false true true false false false false true false true false false true true false true true false false true false true false false false false false false false false true false false false false false false false false false true 255 0 true 346 true false true IS false false false true true false false false false X 9 7 true false false false false false false true true false true true true true true true true true true true false AL AK AZ AR CA CO CT DC FL GA HI IL IN KS KY ME MD MA MI MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X Mark Nadolny 9728551600 5005 LBJ FREEWAY SUITE 250 DALLAS TX 752446125 Dr LaSalle D Leffall Jr 1.0 X 0 0 0 Eric Brinker 1.0 X 0 0 0 Linda Custard 1.0 X 0 0 0 Brenda Lauderback 1.0 X 0 0 0 John D Raffaelli 1.0 X 0 0 0 Linda Law 1.0 X X 0 0 0 Connie O'Neill 1.0 X X 0 0 0 Elyse Gellerman 1.0 X 0 0 0 Jane Abraham 1.0 X 0 0 0 Nancy G Brinker 55.0 X X 684717 0 11430 Elizabeth Thompson 55.0 X 375246 0 16952 Katrina McGhee 55.0 X 319024 0 12373 Mark Nadolny 55.0 X 337696 0 21119 Jonathan Blum 55.0 X 364334 0 20373 Lesley Lurie 55.0 X 185427 0 14811 Eric Winer 20.0 X 210842 0 0 Julie Teer 55.0 X 230378 0 0 David Dawson 55.0 X 220129 0 16220 Margo Lucero 55.0 X 173115 0 21187 Chandini Portteus 55.0 X 171204 0 15006 Nancy Macgregor 55.0 X 198814 0 16787 3470926 0 166258 52 false true false Event 360 Inc 205 N Michigan Avenue CHICAGO IL 606015927 Event Management 10901943 Merkle Response Services Inc PO Box 64897 BALTIMORE MD 21264 DONAT. PROCESS & MKT 6243836 Convio Inc PO Box 671445 DALLAS TX 752671445 Donation processing 4032972 RADARWORKS 6100 WILSHIRE BOULEVARD LOS ANGELES CA 90048 MARKETING 2747791 ADECCO EMPLOYMENT SERVICES 175 BROADHOLLOW ROAD MELVILLE NY 11747 TEMP STAFFING SVCS 1958688 56 316818 78631238 80831608 72070 159779664 Affiliate Payments 900099 33193701 33193701 33193701 3813804 3813804 0 714346 714346 95380157 91242331 4137826 4137826 4137826 4976100 78631238 10638369 -5662269 -5662269 0 754583 821513 -66930 -66930 Support services 900099 800000 800000 Other 900099 378313 378313 1178313 197088455 33926771 0 3382020 X 65717515 65717515 0 5980328 5980328 0 2477286 2105693 247729 123864 0 19786428 13795724 4107634 1883070 656005 445114 151140 59751 2108070 1463039 446303 198728 1284231 896135 263393 124703 0 270166 195866 56209 18091 582329 396810 121162 64357 9832 9832 1160108 1160108 278468 189754 57939 30775 0 19643947 15068310 305117 4270520 13167239 6756535 225866 6184838 4011388 3209111 240683 561594 0 1967443 1388010 404720 174713 3990342 2969674 685147 335521 0 1345225 868673 322872 153680 0 0 1572358 1158736 272070 141552 -33901 -24446 -6149 -3306 CONSULTING AND PROF SERVICES 20956279 16972249 1659321 2324709 EQUIP RENTAL AND MAINTENANCE 1129218 459220 377380 292618 EVENT PRODUCTION 8898293 6834255 390589 1673449 BANK FEES 3519843 380892 34500 3104451 7879775 4352685 661515 2865575 188358215 151589714 11025140 25743361 X 65800029 37451525 6131267 22217237 0 0 50614983 56524309 59432769 45091699 1923864 1158074 0 0 0 0 3861903 4281900 638001 508986 2039706 2016583 12230333 9597471 3701014 2632862 197565607 200889907 0 0 0 0 0 0 0 0 319777847 313104320 32386936 26817905 173362177 166183341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 205749113 193001246 X 66987655 78174629 46816079 41603445 225000 325000 114028734 120103074 319777847 313104320 X 8730240 -2655900 X false true true X false X 132775607 127995868 134999587 174658160 159779664 730208886 0 0 0 0 0 0 0 0 0 0 0 0 132775607 127995868 134999587 174658160 159779664 730208886 1749349 728459537 8682291 6957976 3548746 3812083 4528150 27529246 0 0 0 0 0 0 81914 71369 2589864 84038 378313 3205498 760943630 196229303 0.95731 0.93417 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 0 519831 9832 136387 9832 656218 177323243 345691395 177333075 346347613 1000000 1000000 250000 250000 269831 true 1000000 1000000 1000000 1000000 4000000 6000000 375201 295135 552301 656218 1878855 250000 250000 250000 250000 1000000 1500000 275601 219954 439745 519831 1455131 Lobbying Expenses Schedule C Part II-A Public policy initiatives have the potential to impact people touched by BREAST CANCER. RECOGNIZING THE POWER OF ADVOCACY TO ACCOMPLISH ITS MISSION, KOMEN SUPPORTS LIMITED LOBBYING ACTIVITIES TO ACHIEVE EVIDENCE-BASED POLICY AND LEGISLATIVE SOLUTIONS DESIGNED TO ELIMINATE BREAST CANCER AS A MAJOR HEALTH PROBLEM. 1225000 100000 33 0 33 1325000 1225000 608 0 608 1225000 1225000 4284 -4284 0 0 1225000 1318022 5240 98262 0 1225000 0.75000 0.25000 0.00000 false false 795374 563108 232266 4100227 3625214 475013 7334732 5409149 1925583 2632862 0 0 ENDOWMENTS Schedule D, Part V Two permanent endowments, Goodman-Brinker and Firnberg. Goodman-Brinker Endowment to be used for Breast Cancer Research fellowships. Firnberg Endowment to be used for breast cancer educational programs and research awards. The prior years endowment fund amounts were restated to match the organization's audited financial statements. During Fiscal Year 2012, A third permanent endowment of $100,000 was funded, the earnings of which are restricted for use in the Houston and surrounding counties. FIN 48 (ASC740) Financial Statement Disclosure Schedule D, Part X, Line 2 The Organization is subject to a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. There were no uncertain tax positions recorded in the financial statements at March 31, 2012 and March 31, 2011. true Central America and the Caribbean 0 4 Program Services Educ. & Event Support 17921 East Asia and the Pacific 0 1 Program Services Educ. & Event Support 250 Europe (including Iceland and Greenland) 0 2 Program Services Educ. & Event Support 31433 Middle East and North Africa 0 8 Program Services Educ. & Event Support 68277 North America 0 5 Program Services Educ. & Event Support 7519 Russia and the Newly Independent States 0 1 Program Services Educ. & Event Support 7694 Central America and the Caribbean 0 0 Grantmaking Education Grants 212465 East Asia and the Pacific 0 0 Grantmaking Research Grants 574751 Europe (including Iceland and Greenland) 0 0 Grantmaking Education Grants 383058 Europe (including Iceland and Greenland) 0 0 Grantmaking Research Grants 1498580 Middle East and North Africa 0 0 Grantmaking Education Grants 418980 North America 0 0 Grantmaking Education Grants 643163 North America 0 0 Grantmaking Research Grants 1551040 South America 0 0 Grantmaking Education Grants 408598 South America 0 0 Grantmaking Research Grants 160000 Sub-Saharan Africa 0 0 Grantmaking Education Grants 129692 0 21 0 21 6113421 6113421 Sub-Saharan Africa Education 50000 wire transf Cent. America/Caribbean Education 135000 wire transf North America Education 199308 wire transf Europe/Iceland/Greenland Research 232785 wire transf Middle East/North Africa Education 123950 wire transf Sub-Saharan Africa Education 35000 wire transf North America Research 250000 wire transf North America Education 25000 wire transf Europe/Iceland/Greenland Education 28000 wire transf Europe/Iceland/Greenland Education 10000 wire transf Europe/Iceland/Greenland Education 25000 wire transf South America Education 100257 wire transf Europe/Iceland/Greenland Research 258782 wire transf Cent. America/Caribbean Education 7500 wire transf South America Education 7500 wire transf Cent. America/Caribbean Education 69965 wire transf North America Education 218555 wire transf Europe/Iceland/Greenland Education 25000 wire transf Europe/Iceland/Greenland Research 91954 wire transf South America Research 160000 wire transf South America Education 49997 wire transf Europe/Iceland/Greenland Research 125000 wire transf Europe/Iceland/Greenland Education 94452 wire transf North America Research 154779 wire transf Europe/Iceland/Greenland Research 140000 wire transf Europe/Iceland/Greenland Research 196012 wire transf Europe/Iceland/Greenland Research 122048 wire transf North America Research 779936 wire transf Middle East/North Africa Education 20000 wire transf Middle East/North Africa Education 12900 wire transf East Asia/Pacific Research 199264 wire transf Europe/Iceland/Greenland Education 64200 wire transf Sub-Saharan Africa Education 35000 wire transf South America Education 100844 wire transf North America Research 160000 wire transf Europe/Iceland/Greenland Research 140000 wire transf Europe/Iceland/Greenland Education 136406 wire transf South America Education 150000 wire transf Sub-Saharan Africa Education 9693 wire transf North America Research 161325 wire transf East Asia/Pacific Research 335487 wire transf North America Education 200300 wire transf North America Research 45000 wire transf Europe/Iceland/Greenland Research 192000 wire transf East Asia/Pacific Research 40000 wire transf Middle East/North Africa Education 247130 wire transf 46 false false false false false false Procedures for monitoring Grant Funds outside of the United States Schedule F, Part V All research, education, screening, and treatment grantees are required to submit annual financial and progress reports and change requests for modifications to their project. All reports and requests are reviewed by science staff. See Schedule I, Part IV for more details. X X X X X true Merkle Inc Direct Marketing false 26416121 1158268 25257853 26416121 1158268 25257853 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY GBL RACE FR CUR 5201090 3693202 1507888 8964 20675 151504 3 DAY WALK SE 75691853 72388318 3303535 18729 2357598 2631330 5163101 2 2714395 2549718 164677 9682 42435 221051 13300 83607338 78631238 4976100 37375 2400033 2873056 13300 5314605 10638369 -5662269 Fundraising Events Schedule G, Part II Net income summary Gross receipts are reduced by the amount of contributions per IRS instructions. The contributions for FY 2012 were $78.6 million. true Adventist Healthcare Inc 1801 Research Blvd Suite 300 Rockville MD 20853 521532556 501(c)3 343875 Screening African Wellness Center 186903 Nathans Place Montgomery Village MD 20886 510622960 501(c)3 25000 Screening Albert Einstein College of Med Yeshiva University 1300 Morris Park Ave Bronx NY 10461 131624225 501(c)3 318000 Alexandria Neighborhood Health Services 2 East Glebe Road Alexandria VA 22305 541849891 501(c)3 25000 Education American Association for Cancer Research 615 Chestnut St Philadelphia PA 191064404 236251649 501(c)3 830000 Education American Association on Health & Disabil 110 N Washington St Rockville MD 20854 521884887 501(c)3 150000 Education American Jewish Joint 711 Third Avenue New York NY 100174014 131656634 501(c)3 388964 Education Arlington Free Clinic 2921 11th Street South Arlington VA 22204 541671883 501(c)3 150000 Education Aultman Hospital 26210 Emery RD Cleveland OH 44128 341445390 501(c)3 200000 Research Baylor College Medicine One Baylor Plaza Houston TX 77030 741613878 501(c)3 1438930 Research Beckman Research Inst City of Hope 1500 E Duarte Rd Duarte CA 91010 953432210 501(c)3 20981 Research Beth Israel Deaconess Medical Center 330 Brookline Av Boston MA 02215 042103881 501(c)3 120000 Research Bioethics International 420 Lexington Ave New York NY 10170 870774767 501(c)3 60000 Education Boise State University 1910 University Dr Boise ID 83725 826010706 501(c)3 200000 Research Boston University 580 Harrison Ave 3-W Boston MA 02118 042103547 501(c)3 59138 Research Boston University School of Medicine 85 East Newton St Boston MA 02118 042103547 501(c)3 60000 Research Brigham & Women's Hospital PO Box 3149 Boston MA 022413149 042312909 501(c)3 244788 Research Brown University Box 1929 164 Angell St Providence RI 02912 050390989 501(c)3 200000 Research Burnham Institute for Medical Research 10901 N Toerrey Pines Rd La Jolla CA 92037 510197108 501(c)3 210000 Research California Pacific Medical Center 475 Brannan St San Francisco CA 94107 942728423 501(c)3 287018 Research Cancer Care 275 Seventh Avenue New York NY 10001 131825919 501(c)3 634481 Treatment Cancer Legal Resource Foundation 919 Albany Street Los Angeles CA 90015 952960607 501(c)3 7500 Education Capital Breast Care Center 650 Pennsylvania Ave Washington DC 20003 530196603 501(c)3 150000 Education CASA of Maryland 734 University Bl Silver Spring MD 20903 521372972 501(c)3 186875 Education Case Western Reserve University 10900 Euclid Avenue Cleveland OH 44106 341018992 501(c)3 216048 Research C-Change 1776 I St NW Washington DC 20006 161641769 501(c)3 50000 Education Children's Hospital Boston PO Box 414413 Boston MA 02241 042774441 501(c)3 120000 Research Children's Memorial Hospital 225 E Chicago Chicago IL 60611 363357005 501(c)3 48000 Research Cleveland Clinic Foundation 9500 Euclid Av Cleveland OH 44195 912153073 501(c)3 60000 Research Cold Spring Harbor Laboratory 1 Bungtown Rd Cold Spring Harbor NY 11724 112013303 501(c)3 198000 Research Columbia University Medical Center 722 West 168th St New York NY 10032 135598093 501(c)3 417527 Research Commonweal PO Box 316 Bolinas CA 94924 942366094 501(c)3 68148 Education Conquer Cancer Foundation 2318 Mill Road Alexandria VA 22314 311667995 501(c)3 250000 Education Cornell University Weill Medical College 1300 York Av New York NY 10065 136094042 501(c)3 40000 Research Cornell University Ithaca 120 Day Hall Ithaca NY 14853 150532082 501(c)3 40000 Research Dana Farber Cancer Institute 450 Brookline Ave BP 412 Boston MA 02215 042263040 501(c)3 2532935 Research Dartmouth College 63 South Main St Hanover NH 03755 020222111 501(c)3 207145 Research Delta State University CCED 1417 College St Cleveland MS 38733 646026565 501(c)3 20000 Education Duke University Medical Center 2200 W Main St Ste 820 Durham NC 27705 560532129 501(c)3 2237111 Research ECOG Research and Education Foundation 1818 Market St Philadelphia PA 19109 391723095 501(c)3 171200 Research Emory University Winship Cancer Inst PO Box 935084 Atlanta GA 31193 580566256 501(c)3 60000 Research EO Lawrence Berkeley National Laboratory University of California Berkeley CA 94701 942951741 501(c)3 200000 Research Facing Our Risk of Cancer Empowered 16057 Tampa Palms Blvd Tampa FL 33647 650927702 501(c)3 100000 Education Fannie Lou Hamer Cancer Foundation 2600 Browning Road Greenwood MS 38930 861118042 501(c)3 20000 Education Fox Chase Cancer Center 333 Cottman Avenue Philadelphia PA 19111 223524939 501(c)3 60000 Research Fred Hutchinson Cancer Research Center 1100 Fairview Av N Seattle WA 98109 563744111 501(c)3 600000 Research Friends of Cancer Research 2231 Crystal Dr Arlington VA 22202 521983273 501(c)3 35000 Education George Washington University 45155 Research Pl Ashburn VA 20147 530196584 501(c)3 106927 Research Georgetown U Bldg D NW Washington DC 200571411 530196603 501(c)3 1429076 Research Harvard Medical School 1350 Massachusetts Av Cambridge MA 02138 042103580 501(c)3 348581 Education Harvard University 25 Shattuck Street Boston MA 02115 042103580 501(c)3 60000 Research Henry Ford Health System 1 Ford Place 5E Detroit MI 48202 381357020 501(c)3 199616 Research Herald Cancer Association 715 E Mission Road San Gabriel CA 91776 133156738 501(c)3 70000 Education Holy Cross Hospital 1500 Forest Glen Rd Silver Spring MD 20910 590791028 501(c)3 250000 Education Indiana U (Indianapolis) PO Box 66057 Indianapolis IN 462666057 356001673 501(c)3 1771825 Research Inova Health System Foundation 2700 Prosperity Avenue Fairfax VA 22031 541071867 501(c)3 75000 Education International Breast Cancer 660 John Nolan Dr Madison WI 53711 391766858 501(c)3 146394 Research International Scholarship & Tuition Serv 200 Crutchfield Ave Nashville TN 37210 621247492 501(c)3 294251 Education John Wayne Cancer Institute Molecular Oncology 2200 S Monica Blvd Santa Monica CA 90404 954291515 501(c)3 80000 Research Johns Hopkins U 1101 East 33rd St Baltimore MD 21218 520595110 501(c)3 2511037 Research Karmanos Cancer Institute 4100 John R Detroit MI 48201 381613280 501(c)3 213035 Research Korean Community Service Center of Greater WA 7700 Lt River Turnpike Annandale VA 22003 113186054 501(c)3 90000 Education Lankenau Institute for Medical Research 100 Lancaster Ave Wynnewood PA 19096 232175659 501(c)3 391460 Research Lawrence Berkeley National Laboratory PO Box 528 Berkeley CA 94701 942951741 501(c)3 57914 Research Loyola University 820 N Michigan Ave Chicago IL 60611 361408475 501(c)3 159554 Research Mary's Center for Maternal & Child Care Inc 2333 Ontario Road NW Washington DC 20009 521594116 501(c)3 100000 Education Massachusetts General Hospital 101 Huntinton Ave Ste 3 Boston MA 02199 042697983 501(c)3 425721 Research Mayo Clinic and Foundation 4500 San Pablo Rd Jacksonville FL 32224 416011702 501(c)3 350000 Research Mayo Clinic Jacksonville 4500 San Pablo Rd Jacksonville FL 32224 416011702 501(c)3 220003 Research Mayo Clinic Rochester 200 First St SW Rochester MN 55903 416011702 501(c)3 832022 Research Mazzoni Center 21 S 12th St Philadelphia PA 19107 232176338 501(c)3 10000 Research Medical College 8701 Watertown Plk Rd Milwaukee WI 53226 390806261 501(c)3 200000 Research Memorial Sloan-Kettering Cancer Ctr 1275 York Ave New York NY 10021 131924236 501(c)3 747114 Research Mercy Health Foundation 301 St Paul Place Baltimore MD 21202 522173656 501(c)3 15000 Research Mercy Medical Center 301 St Paul Place Baltimore MD 21202 520591658 501(c)3 348806 Research Methodist Hospital Research Institute 6565 Fannin Houston TX 77030 870721923 501(c)3 59930 Research Metropolitan Chicago Breast Cancer 1645 Jackson Blvd Chicago IL 60612 262264895 501(c)3 424999 Screening Michigan State University 301 Admin Bldg East Lansing MI 48824 386005984 501(c)3 150000 Research Mississippi State Department of Health 570 E Woodrow Wilson Jackson MS 39215 646000775 501(c)3 46239 Education Mount Sinai School of Medicine 1 Gustave L Levy Pl New York NY 10029 136171197 501(c)3 439957 Research Muslim Community Center Medical Clinic 15200 Newhampshire Ave Silver Spr MD 20905 521072792 501(c)3 24990 Screening National Academy of Sciences 730 15th Street NW Washington DC 20005 530196932 501(c)3 8139 Research National Cancer Institute Building 31 Room 11A-48 Bethesda MD 20892 521986675 501(c)3 500000 Research New York University 665 Broadway New York NY 10012 135562308 501(c)3 40000 Research New York University School of Med One Park Ave New York NY 10016 135562308 501(c)3 320000 Research Northwestern Univ - Evanston 633 Clark St Evanston IL 60208 362167817 501(c)3 359936 Research NOVA Research Company 4600 EW Highway Bethesda MD 20814 521477125 501(c)3 6800 Education Nueva Vida 2000 P Street NW Washington DC 20036 251410081 501(c)3 100000 Education Ohio State University College of Med 333 West 10th Ave Columbus OH 43210 316025986 501(c)3 120000 Research Oregon Health & Science University 0690 SW Bancroft St Portland OR 97239 237083114 501(c)3 566171 Research Patient Advocate Foundation 421 Butler Farm Rd Hampton VA 23666 541806317 501(c)3 1000000 Treatment Penfold-Patterson Research Institute 1700 El Camino Real Menlo Park CA 94025 270578063 501(c)3 400000 Research Pennsylvania State Univ College of Medi H138 500 University Dr Hershey PA 17033 236298308 501(c)3 160344 Research Prevent Cancer Foundation 1600 Duke Street Alexandria VA 22314 521429544 501(c)3 99950 Education Primary Care Coalition-Montgomery Cty Inc 8757 Georgia Ave Silver Spring MD 20910 521847976 501(c)3 561745 Screening Prince George's County Health Dept 1801 McCormick Dr Largo MD 20774 522046026 501(c)3 40000 Education Princeton University 701 Carnegie Center Princeton NJ 08540 210634501 501(c)3 256250 Research Proteogenomics Research Institute 11107 Roselle St San Diego CA 92121 800418281 501(c)3 200000 Research Providence Health Foundation 1150 Varnum Street NE Washington DC 20017 521275583 501(c)3 500000 Screening Providence Portland Medical Center PO Box 13993 Portland OR 97213 930386906 501(c)3 197963 Research Purdue University 23510 Network Place Chicago IL 60673 356002041 501(c)3 79979 Research Quantum Leap HealthCare Collaborative 320 Fairway Drive Half Moon Bay CA 94019 204284925 501(c)3 38000 Education ReaganUdall Foundation 800 I Street NW Washington DC 20001 263727917 501(c)3 90000 Education Research Advocacy Network 6505 W Park Blvd Plano TX 75093 352209499 501(c)3 79440 Education Research Foundation of SUNY 35 State Street Albany NY 12207 141368361 501(c)3 48000 Research Roswell Park Alliance Foundation Roswell Pk Cancer Inst Buffalo NY 14263 161391608 501(c)3 20000 Research Sanford Research 2301 East 60th St N Sioux Falls SD 57104 363297853 501(c)3 120000 Research Scripps Research Institute 10550 N Torrey Pines Rd La Jolla CA 92037 330435954 501(c)3 105000 Research Smith Farm Center for Healing & the Arts 1632 U Street NW Washington DC 20009 521977976 501(c)3 233333 Education Society for Surgical Oncology 85 W Algonquin Rd Arlington Hts IL 60005 136161070 501(c)3 57500 Research Society for Women's Health Research 1025 Connecticut Av NW Washington DC 20036 521694732 501(c)3 755015 Research Southern Illinois University PO Box 19616 Springfield IL 62794 376005961 501(c)3 11982 Research Stanford University PO Box 44253 San Francisco CA 94144 941156365 501(c)3 553082 Research SUNY at Buffalo 402 Crofts Hall Buffalo NY 14260 166020461 501(c)3 115798 Research SUNY at Stony Brook PO Box 9 Albany NY 12201 141368361 501(c)3 467432 Research The ASCO Cancer Foundation 1900 Duke St Alexandria VA 22314 311667995 501(c)3 2475000 Education The General Hospital Corp 50 Staniford ST Boston MA 02114 041564655 501(c)3 983687 Research The Hope Foundation PO Box 483 Ann Arbor MI 48106 742655302 501(c)3 683200 Research The Mautner Project 1300 19th Street NW Washington DC 20036 521703915 501(c)3 100000 Education The Ohio State University College 700 Childrens Dr Columbus OH 43205 381746722 501(c)3 24868 Research The Red Devils PO Box 36291 Towson MD 21286 743070929 501(c)3 50000 Treatment The Salk Institute 10010 N Torrey Pines Rd La Jolla CA 92037 956136024 501(c)3 200000 Research The University of Chicago 970 East 58th ST Chicago IL 60637 362177139 501(c)3 200000 Research The Wistar Institute 3601 Spruce Street Philadelphia PA 19104 236434390 501(c)3 174797 Research Thomas Jefferson University 201 S 11th St Philadelphia PA 19107 232840151 501(c)3 1991793 Research Tom Lantos Foundation for Human Rights 19 Pleasant Street Concord NH 03301 352325429 501(c)3 10000 Education Translational Genomics Research Institute 445 N Fifth Street Phoenix AZ 85004 753065445 501(c)3 88637 Research Trustees of Boston University 25 Buick Street Boston MA 02215 042103547 501(c)3 158858 Research Trustees of Columbia Univ 722 West 168 St New York NY 10032 133957095 501(c)3 200000 Research Tufts University 136 Harrison Ave Boston MA 02111 043532914 501(c)3 436760 Research Univ of Arkansas for Medical Science 4301 W Markham Little Rock AR 72205 716056774 501(c)3 19531 Education Univ of Colo Denver Health Sciences Ctr PO Box 910238 Denver CO 80291 846000555 501(c)3 648146 Research Univ of Kentucky Research Foundation PO Box 931113 Cleveland OH 41193 616033693 501(c)3 491553 Research Univ of Louisville Rsrch Foundation Inc 521 Stevenson Hall Louisville KY 40292 611029626 501(c)3 107978 Research Univ of North Carolina at Chapel Hill 104 Airport Dr Chapel Hill NC 27599 566001393 501(c)3 547256 Research Univ of North Carolina at Charlotte 9201 Univ Cty Blvd Charlotte NC 28223 566059417 501(c)3 60000 Research Univ of Southern California 1540 Alcazar Street Los Angeles CA 90033 951642394 501(c)3 210869 Research Univ of Texas MD Anderson Cancer Center PO Box 4390 Houston TX 772104390 746001118 501(c)3 1801398 Research Univ of PA School of Medicine 3451 Walnut Street Philadelphia PA 19104 231352685 501(c)3 120000 Research University Miami School of Medicine Offc of Exp Comp Miami FL 33136 590624458 501(c)3 885904 Research University of Alabama at Birmingham 1720 2nd Avenue South Birmingham AL 35294 636005396 501(c)3 1704949 Research University of Arizona PO Box 44390 Tucson AZ 85733 742652689 501(c)3 20000 Research University of California - Santa Cruz 1156 High Street Santa Cruz CA 95064 941539563 501(c)3 60000 Research University of California - Davis PO Box 989062 West Sacramento CA 95798 946036494 501(c)3 449157 Research University of California - Irvine Biological Science 3 Irvine CA 92697 952226406 501(c)3 260000 Research University of CA - San Diego 9500 Gilman Dr La Jolla CA 92093 956006144 501(c)3 695698 Research University of California - San Francis 3333 California St San Francisco CA 94118 946036493 501(c)3 3400047 Research University of California - Los Angeles 10920 Wilshire Blvd Los Angeles CA 90024 956006143 501(c)3 535000 Research University of Central Florida 12424 Research Pkwy Orlando FL 32828 593086453 501(c)3 349442 Research University of Cincinnatti 51 Goodman Dr Cincinnati OH 45221 316000989 501(c)3 420582 Research University of Colorado Health Sciences C 13001 E 17th Pl Aurora CO 80045 846000555 501(c)3 166085 Research University of Florida 219 Grinter Hall Gainesville FL 32611 590974739 501(c)3 160000 Research University of Hawaii 2530 Dole Street Honolulu HI 96822 996000354 501(c)3 9880 Research University of Houston PO Box 988 Houston TX 77001 746001399 501(c)3 264726 Research University of Illinois at Chicago 809 S Marshfield Ave Chicago IL 60608 376000511 501(c)3 328466 Research University of Iowa at Carver College B5 Jessup Hall Iowa City IA 52242 426004813 501(c)3 48000 Research University of Kansas Medical Center 3901 Rainbow Blvd Kansas City KS 66160 481108830 501(c)3 612646 Research University of Louisville 521 Stevenson Hall Louisville KY 40292 611029626 501(c)3 467440 Research University of Maryland at Baltimore PO Box 41428 Baltimore MA 20203 311678679 501(c)3 770001 Research University of Massachusetts Amherst Goodell Bldg Box 33210 Amherst MA 01003 542084125 501(c)3 6587 Research University of Michigan Wolverine Tower Ann Arbor MI 481091274 386006309 501(c)3 2112387 Research University of Minnesota 200 Oak St SE Minneapolis MN 55455 416007513 501(c)3 950279 Research University of Missouri 341 Woods Hall St Louis MO 63121 436003859 501(c)3 27194 Research University of Nebraska 985100 Nebraska Med Ctr Omaha NE 68198 470049123 501(c)3 280000 Research University of North Carolina 104 Airport Dr Chapel Hill NC 27599 566001393 501(c)3 176232 Research University of North Dakota 264 Centennial Dr Grand Forks ND 58202 203332779 501(c)3 40000 Research University of Oklahoma Health Sciences C 1100 N Lindsay Oklahoma City OK 73104 736017987 501(c)3 216127 Research University of Pennsylvania 3451 Walnut St Philadelphia PA 19104 231352685 501(c)3 260000 Research University of Pittsburgh 139 University Place Pittsburgh PA 15260 250966691 501(c)3 308000 Research University of Portland 5000 N Willmette Blvd Portland OR 97203 930401259 501(c)3 50000 Education University of Rochester 1325 Mt Hope Ave Rochester NY 14620 160743209 501(c)3 29986 Research University of South Dakota 2301 East 60th St N Sioux Falls SD 57104 466018891 501(c)3 197098 Research University of Southern California 1540 Alcazar Street Los Angeles CA 90033 951642394 501(c)3 60000 Research University of Tennessee 1924 Alcoa Hwy Knoxville TN 37920 311626179 501(c)3 212608 Research University of Texas at Health Science CTR 7000 Fannin Street Houston TX 77030 741586031 501(c)3 254820 Research University of Texas Health Science Ctr 7703 Floyd Curl Dr San Antonio TX 78229 741761309 501(c)3 200000 Research University of Utah 75 South 2000 Salt Lake City UT 84112 876000525 501(c)3 86179 Research University of Vermont 85 S Prospect St Burlington VT 05405 030179440 501(c)3 126958 Research University of Virginia PO Box 400195 Charlottesville VA 22904 541682176 501(c)3 229920 Research University of Washington 3917 University Way NE Seattle WA 98105 916001537 501(c)3 653190 Research University of Wisconsin - Madison 21 North Park St Madison WI 53715 396006492 501(c)3 547009 Research UNT Health Science Center 3500 Camp Bowie Blvd Fort Worth TX 76107 756064033 501(c)3 60000 Research UT HSC - San Antonio 7703 Floyd Curl Dr San Antonio TX 77229 741586031 501(c)3 220000 Research UT HSC - Houston PO Box 203382 Houston TX 77216 741761309 501(c)3 31257 Research UT Southwestern Medical Center at Dallas PO Box 841753 Dallas TX 752841753 756002868 501(c)3 128924 Education UTMD Anderson Cancer Ctr 1515 Holcombe Blvd Houston TX 770304009 746001118 501(c)3 5002462 Research Vanderbilt University Medical Center 3319 West End Ave Nashville TN 372038480 620476822 501(c)3 932235 Research Vietnamese Resettlement Association 6131 Willston Dr Falls Church VA 22044 541512549 501(c)3 100000 Education Wake Forest Baptist Med Center Medical Ctr Blvd WinstonSalem NC 27157 560552787 501(c)3 11837 Research Wake Forest University Health Sciences Medical Center Blvd WinstonSalem NC 27157 223849199 501(c)3 200000 Research Washington Cancer Institute 110 Irving Street NW Washington DC 20010 521791670 501(c)3 150000 Education Washington University at St Louis 660 S Euclid Ave St Louis MO 63110 430653611 501(c)3 3371090 Research Wayne State University 5057 Woodward Ave13th Fl Detroit MI 48202 383555142 501(c)3 365652 Research Weill Medical College of Cornell Univ 575 Lexington Avenue New York NY 10022 136094042 501(c)3 48000 Research West Virginia University 886 Chestnut Ridge Rd Morgantown WV 26506 550665758 501(c)3 450000 Research Whitehead Inst for Biomedical Research 9 Cambridge Center Cambridge MA 02142 061043412 501(c)3 264000 Research Yale University 47 College Street New Haven CT 06510 060646973 501(c)3 844974 Research 182 0 Form 990, Schedule I Description of Organization's Procedures for Monitoring the Use of Grants Susan G. Komen for the Cure's (the Organization) policies for managing research grants from the time of initial award through completion seek to maximize flexibility while maintaining the highest standard of accountability and preserving the integrity of the peer review and funding process. Throughout the term of the grant, scientific progress is monitored by a Science Manager assigned to the grant. Grantee is required to submit scientific progress reports on each anniversary of the grant start date for the duration of the project, except for the final year of the grant when a final report is due no later than 30 days after the end date of the grant term. An annual scientific progress report also is due if the Grantee is requesting an extension to the end of the grant term or acceleration of the Grant term. Progress reports must include the following sections: Hypothesis and Specific Aims: A description of progress made during the reporting period for each Aim, data supporting the described progress, justification for delays, the projected completion date for research addressing the specific aim, and current status. Research Outcome Highlight: A list of the research accomplishments during the reporting period. Publications, Presentations & Posters: A list of all manuscripts submitted during the reporting period that are related to the research project, in press or published, with full citation information and a list of all posters displayed or presentations delivered at scientific meetings during the reporting period. Patents, Products, Copyrights & Intellectual Property: A list of all patents or patent applications filed during the reporting period and a list of specific research products developed during the reporting period. Examples of products include novel therapeutic targets, biomarkers, vectors, novel therapies, risk assessment tools and/or algorithms, new technologies, educational materials, etc. Professional Awards & Promotions: A list of all professional awards and promotions received by any of the key personnel during the reporting period. Research Conclusions (Final Reports Only): A brief narrative followed by a bulleted or numbered list of the key outcomes, research accomplishments, and conclusions for the research project; a brief description of the future prospects or next steps in the line of inquiry; a summary evaluating the impact of Komen funding on the research, and for training grants, on the career development of the trainee. Scientific progress reports are submitted online via proposal CENTRAL using the templates provided by Komen. With reasonable prior notice to Grantee, the Organization may require additional reporting from Grantee and also may require Grantee to participate in site visits, telephone conferences, presentations or other speaking engagements. All Grant funds must be expended in accordance with the project's approved budget. Komen will disburse the first year's budgeted Grant funds within thirty (30) days of the effective date of the Grant. For each additional year, excluding the final year of the Grant term, Komen will disburse one hundred percent (100%) of the budgeted funds for that year after review and approval of a satisfactory and timely scientific progress report and financial report for the prior year, updated IACUC/IRB approvals (as applicable), and any other documents requested by Komen for its approval. For the final year of the Grant, Komen will disburse eighty percent (80%) of the approved budget funds after review and approval of a satisfactory scientific progress report and financial report for the prior year, and the submission of updated IACUC/IRB (as applicable), and any other documents requested by Komen for approval. The remaining twenty percent (20%) of funds will be disbursed upon receipt of a satisfactory final research report, final financial report, and any other documents required by Komen. As part of its oversight of research progress, Komen may adjust the project reporting period and associated disbursement of Grant funds at any time during the Grant term with prior written notice to Grantee. Annual financial reports are due no later than 30 days after each anniversary of the Grant start date for the duration of the grant term, with the exception of the final financial report, which is due no later than 60 days after the end date of the Grant term. All expenditures must be reported in United States dollars ($USD). Grantee must submit a Request for Budget Change form in PC in the event Grantee wishes to move funds across budget categories in excess of the allowable limits. Any unexpended funds must be remitted with final financial report to the Organization, unless otherwise directed by the Organization. Komen will not be responsible for a) any expenditure made prior to the effective date or after the termination of the Grant, b) commitments made during the Grant term but not paid within sixty (60) days following the expiration of the Grant Agreement, c) expenditures that are not permitted as described within the RFA, or d) any expenditure that is inconsistent with the approved Research Plan and budget or that exceeds the total amount of the Grant. Komen or its designated representatives shall have the right to request and receive from the Grantee Institution and PI, Co-PI and Mentor, as well as the institutions and principal investigators, co-principal investigators and mentors involved in any consortium or subcontract, copies of any and all documents and other information related to the Grant at any time during or after the term of the Grant. This right includes, but is not limited to, the right to review all financial books and records related to the Grant and to perform an audit or other accounting procedures of all expenses related directly or indirectly to the Grant. The Organization's policies for managing community grants and other non-research related grants from the time of initial award through completion seek to maximize flexibility while maintaining the highest standard of accountability and preserving the integrity of the peer review and funding process. All grantees must sign a grant contract which sets forth the terms of the grant, including the purpose of the grant, amount, budgetary restrictions, duration payment schedule, reporting requirements, and audit and early termination rights for the Organization. The grantee is required to submit progress reports (typically every six months) that detail progress towards meeting each of the objectives and any challenges encountered. The report must also include a full accounting of grant funds awarded (actual versus budgeted expenses). The Program Manager conducts site visits with the grantees when appropriate to build a stronger relationship with the grantee; to gain a better understanding of its work; and to address any challenges or problems the grantee is facing. Any changes to the project must be approved by the Organization's Program Manager in writing in advance of the change. A final report must be provided within 45 days after the completion or early termination of the grant and must include evaluation of the program's accomplishments and impact in the community. Any unexpended funds must be remitted with the final report and final financial report to the Organization unless otherwise directed by the Organization. X true true X X X X X true false false false false true false false false Nancy G Brinker 548765 0 124450 0 11502 0 10195 0 1235 0 696147 0 0 0 Elizabeth Thompson 321726 0 51000 0 2520 0 9980 0 6972 0 392198 0 0 0 Katrina McGhee 277068 0 39750 0 2206 0 10056 0 2317 0 331397 0 0 0 Mark Nadolny 289379 0 44137 0 4180 0 13528 0 7591 0 358815 0 0 0 Jonathan Blum 200862 0 33863 0 129609 0 10066 0 10307 0 384707 0 0 0 Lesley Lurie 167850 0 15445 0 2132 0 10124 0 4687 0 200238 0 0 0 Eric Winer 183842 0 27000 0 0 0 0 0 0 0 210842 0 0 0 Julie Teer 202931 0 25450 0 1997 0 0 0 0 0 230378 0 0 0 David Dawson 195759 0 22325 0 2045 0 9248 0 6972 0 236349 0 0 0 Margo Lucero 153513 0 17650 0 1952 0 10715 0 10472 0 194302 0 0 0 Chandini Portteus 154843 0 14670 0 1691 0 10448 0 4558 0 186210 0 0 0 Nancy Macgregor 173964 0 21450 0 3400 0 12015 0 4772 0 215601 0 0 0 Supplemental Compensation Information Schedule J, Part I, Line 1a First class and business class fares for domestic travel, Canada, the Caribbean, Central America, and Mexico are not reimbursable. However, personal frequent flier mileage and/or coupons may be used for no-cost upgrades. Only the CEO/Founder is approved for first class travel. Whenever possible, discounted first class and upgrades are used to minimize cost. Schedule J, Part I, line 4a A severance payment was made to Jonathan Blum during calendar year 2011. Schedule J, Part I, Line 6a The Smartpay Incentive Plan is designed to drive organizational performance, enhance the organization's competitive pay position and positively affect our ability to attract and retain talent. Currently annual operational financial performance at headquarters must provide full funding of the board approved budgeted slate of research grants and mission activity while ensuring adjusted net operating activity remains at breakeven. This Smartpay Incentive Plan is an annual program, giving full discretion to the organization's board of directors for renewal, suspension, or termination of the plan. The Smartpay Incentive Plan is available to all employees of the parent who meet eligibility requirements. $1,301,999 was paid out during calendar year 2011. X 3 43770 cost or sale price X Desk 1 150 cost or sale price X Golf putters,hd cov,pouches 1050 28150 cost or sale price false true false Volunteers Form 990, Part I, Question 6 Volunteers serve in a variety of ways but the greatest number of volunteers assist with the Breast Cancer 3 Day series. Program Service Accomplishments Part III Nancy G. Brinker promised her dying sister, Susan G. Komen, that she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure (Komen) and launched the global breast cancer movement. Today, Susan G. Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Race for the Cure, Komen and its Affiliates have invested $2.2 billion to fulfill its promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. A - Research and Training Komen has contributed to major advances in breast cancer research over the past 30 years. Komen's Research Programs are designed to advance the translation of research discoveries into new ways to diagnose, treat, and prevent breast cancer, leading to a reduction of breast cancer incidence and mortality within the next decade. To ensure maximum impact for its research dollars, Komen is guided by a Scientific Advisory Board, a group of internationally recognized doctors, scientists and advocates, and consults with the Komen Scholars, a group comprised of 68 scientists and advocates. Komen awards grants to individual scientists, research teams, and organizations around the world through competitive, review processes that ensure maximum impact for our research dollars. In fiscal year 2012, Komen made 144 grants through its Research and Training Grants Program to support research and training in the United States and other countries, including Australia, Belgium, and Canada. The following Request for Applications (RFA) driven grant opportunities were offered by Komen during fiscal year 2012: -Promise Grants: Large-scale grants, up to $4.2 million each, during a three-year period, targeted to research that seeks to understand and prevent late recurrence of breast cancer. -Post-Doctoral Fellowships: Grants of $60,000 per year for two or three years, to attract, train, and retain promising young researchers into the field of breast cancer research. -Career Catalyst Research: Grants of $150,000 per year for two to three years, to fill a critical gap in support and stimulate the transition from training to independence among promising cancer investigators. -Investigator Initiated Research: Grants of up to $25,000 per year for three to four years, to explore new ideas and approaches with significant potential to lead to reductions in breast cancer mortality and/or incidence within the decade. -Post Baccalaureate in Disparities Research: Grants up to $135,000 per year over three years, to support training programs for graduate students in the area of breast cancer disparities in breast cancer outcomes across population groups. The grant slate approved for funding through the above-referenced opportunities is comprised of the following: -The majority of the grants will address important questions related to the biology of breast cancer (46%), including understanding chromosomal changes in the initiation of breast cancer, the role of oncogenes and tumor suppressor genes. -Of the biology-based projects, the major focus of these projects is on breast cancer progression and metastasis. -Grants addressing methods for treatment, with significant focus on discovery and development of systemic therapies, are the second highest concentration of grants (27%) . -Grants addressing early detection, diagnosis and prognosis, with significant focus on biomarker discovery, validation, and application comprise 12% of the grant slate. -Grants addressing the exogenous and endogenous causes of breast cancer (etiology) comprise 5% of the grant slate. -Grants investigating issues related to cancer control, survivorship, and outcomes comprise 6% of the grant slate. -Grants focusing on strategies to prevent breast cancer, such as through the use of vaccines and personal behavior interventions, comprise 4% of the grant slate. Below are specific examples of promising research and training grants committed in fiscal year 2012: -A $4 million Promise Grant to Drs. Matthew Ellis and Pascal Meier, of Washington University in St. Louis to better identify which women with ER-positive disease are at highest risk for late recurrence, and then targeting those at high risk with more effective therapies. The team will study changes in the DNA structure of breast cancer cells versus normal cells, and develop better ways to kill the breast cancer cells before they spread. -A $4 million Promise Grant to Drs. Bert O'Malley and Kent Osborne, at Baylor College of Medicine in Houston, to identify women who will not benefit from the most commonly used therapies today - tamoxifen or aromatase inhibitors - and develop new therapies for women with this form of the disease. This study may lead to the first new drug in years to prevent recurrence in women with ER-positive breast cancer. -A $250,000 Scholar Grant to Dr. Anne McTiernan, of the Fred Hutchinson Cancer Research Center in Seattle, to investigate the incremental effect of vitamin D supplementation in overweight and obese postmenopausal women with low blood vitamin D levels on response to a weight loss (diet + exercise) intervention. The proposed research will provide important information about vitamin D insufficiency and weight, two potentially modifiable risk factors for breast cancer. -A $888,000 Investigator-Initiated Research Grant to Dr. Michelle Cote, of Wayne State University, to study markers to identify African American women at the highest risk for developing breast cancer. -A $250,000 Scholar Grant to Dr. Mary-Claire King, of the University of Washington in Seattle, to identify new genes that will better identify women at risk for inherited breast cancer -A $450,000 Career Catalyst Research Grant to Dr. Keith Bahjat, of Providence Portland Medical Center, to develop a vaccine against a gene commonly seen in HER-2 positive breast cancer, which represents 15 to 20 percent of breast cancer cases. The hope is to combine vaccine therapy with treatment drugs to prevent recurrence. -A $450,000 Career Catalyst Research Grant to Dr. Elisabeth Battinelli, of Brigham and Woman's Hospital in Boston, to understand why some blood-clot medicines like heparin are leading to prolonged survival and less metastatic disease in breast cancer patients. Komen also supported dozens of partnerships and special projects to advance research and our understanding of breast cancer around the world. These grants respond to unique opportunities, leverage the work of different organizations, and address critical challenges and cross-cutting issues in research, clinical practice, and public health. Examples of special projects committed in fiscal year 2012 include the following: RxPONDER: Rx for Positive Node, Endocrine Responsive Breast Cancer (SWOG-S1007) - $250,000 to provide funding for the cost of Oncotype DX testing for women participating in the Phase III clinical trial called RxPONDER (Rx for Positive Node, Endocrine Responsive Breast Cancer) who are uninsured or whose insurance companies will not reimburse for the test. The RxPONDER trial will help determine whether multi-gene tumor assays (Oncotype DX) can be used to identify women with node-positive breast cancer who could forego chemotherapy. Institute of Medicine (IOM) - Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population - $50,000 to support an IOM consensus study to examine issues in the quality of cancer care with an emphasis on shifting demographics in the US that will rapidly accelerate the number of new cancer diagnoses at a time when oncology workforce shortages are predicted. The study considers quality of care from the perspectives of key stakeholders, including patients, health care providers, and payers; examines opportunities for and challenges to the delivery of high quality cancer care to an aging population, including the impact of health care reform and disparities of care; and formulates recommendations for improvements. Program Service Accomplishments (Contd) B - Education Komen is a trusted source of breast health and breast cancer information for people all over the world and is instrumental in connecting people with the resources they need in their fight against breast cancer. Our award-winning website, www.komen.org, provides safe, accurate, comprehensive, and unbiased information about breast cancer based upon scientific evidence, as well as information about our research programs, community programs, volunteer opportunities, and events. The "Understanding Breast Cancer" section of the website, co-developed with Harvard Medical School faculty and Dana-Farber/Brigham and Women's Cancer Center staff, received over 2.5 million visits during fiscal year 2012. Komen also produced evidence-based, easy-to-read educational materials. Komen and its Affiliates distributed nearly 6 million educational materials in fiscal year 2012. Examples of Komen educational materials include the following: - Breast Self-Awareness cards in 19 languages for 22 specific audiences - General breast health awareness and breast cancer specific brochures and fact sheets - Booklets with support information for survivors and co-survivors Komen's trained and caring breast care helpline staff (1-877 GO KOMEN) provide answers to questions, local resources and moral support. Last fiscal year, the Susan G. Komen for the Cure breast cancer helpline responded to over 13,000 calls and 1,100 emails. While older African American women are less likely to be diagnosed with breast cancer than Caucasian women, they are more likely to die from the disease at every age. Susan G. Komen for the Cure's Circle of Promise program engages African American women, and black women around the world, in the fight against breast cancer. At the end of fiscal year 2012, a total of 100,000 ambassadors had been recruited to do the following: - Mobilize the community to ensure that women everywhere have access to the care they need; - Empower women to make a promise to reclaim their lives, their health and to be strong advocates in their communities; and - Dispel myths in the African American community that prevent women from getting early treatment for breast cancer. I AM THE CURE is an educational program that teaches simple, action-oriented, breast health information to participants in the Susan G. Komen Race for the Cure series. Last year, nearly 1.7 million people participated in a Race for the Cure event. A formal evaluation showed that 82% of participants recalled the message that early detection is key to survival. The mobile community education and outreach tour, Komen On the Go, shares important information about breast cancer with all generations across the country. From inner cities to community festivals, public universities to neighborhood centers, Komen On The Go signature bright pink vehicles are teaching Americans everywhere to take charge of their breast health and empowering participants to share information with friends and join the breast cancer movement. During fiscal year 2012, Komen on the Go was on exhibit for more than 87 days in 30 communities across the United States, educating more than 62,000 people with important breast health information and reaching nearly one million people through social media engagement. Cancer kills more people, worldwide, than TB, HIV/AIDS and malaria combined. Komen is waging the global fight against breast cancer by building and strengthening grassroots programs through networking, training, capacity building and financial support. In fiscal year 2012, 292 breast cancer advocates in six countries (Brazil, Costa Rica, Mexico, Panama, Romania, and Ukraine) were trained on the Community Educators program and Course for the Cure curricula. The Community Educators program is a theory-based trainer curriculum targeted for education program planners and Course for the Cure is a series of capacity building modules based on Komen's best practices and experience aimed at helping local non-government organizations increase their reach and impact. In partnership with the Caterpillar Foundation, grant programs in Brazil, Panama, and Mexico reached an estimated 4.6 million people through awareness campaigns and trained 2,715 community health workers, medical providers and Caterpillar employees on breast self awareness and breast cancer. Also, these grants provided for the distribution of 152,774 educational materials, 144 clinical breast exams, 745 mammogram referrals, and 89 mammograms. Komen also awarded grants for outreach programs in Bosnia and Herzegovina, Brazil, China, Egypt, Ghana, Hebron, Hungary, Israel, Jordan, Montenegro, Peru, Romania, Russia, South Africa, Switzerland, Taiwan, Ukraine, Zambia and for conferences in Lithuania and Spain. Program Service Accomplishments (Contd) C - Screening Getting regular screening tests is the best way for women to lower their risk of dying from breast cancer. Screening tests can find breast cancer early, when it's most treatable. Komen supports free and low-cost mammogram programs in communities for women without health insurance or those with high co-pays and deductibles that make getting a mammogram too costly. In 2012, Komen awarded $4 million in new community grants to reach low-income, minority and uninsured women who fall through the healthcare gaps in the Washington, D.C. Metro area, where death rates from breast cancer continue to rank above national averages. The new Komen grants bring to 30 the number of Komen-funded programs in the D.C. area that strive to improve access and services to women facing breast cancer, representing a total in active grant funding of $11 million during 2011 and 2012. The five largest grants ($2,500,000 in 2012 and $1,917,000 in 2011) in the Washington, D.C. Metro area focus on addressing barriers to care caused by the area's overly fragmented heath care system. They encourage partnerships between providers in the region that establish a framework to ensure that patients can be easily and efficiently referred and "navigated" from screening all the way through to survivorship-with particular emphasis on removing obstacles to transportation and work obligations, wait times, and financial assistance. Fourteen grants ($2,779,981-eleven of which are continued from 2011; three of which are new in 2012) focus on patient education, including targeted breast health awareness outreach in a culturally sensitive manner that develops a better understanding of the importance of screening, the effectiveness of modern treatments and survivorship. Two grants ($400,000-programs continued from 2011) focus on provider education, helping doctors and other breast health providers develop a better understanding of the myths, fears and unique needs of the different cultural populations of the women they serve. The programs educate providers about updated screening guidelines, and how best to help refer patients through the complex web of screening, diagnosis, treatment and follow-up care. Two grants ($626,476 total in 2012 ) were awarded as part of the National Capital Area Continuum of Care Special Initiative. The purpose of this special funding initiative is to decrease the time it takes for a person to move from early detection and diagnosis to treatment and recovery; to increase mammography rates; change attitudes, knowledge and beliefs, and improve quality of life for patients going through treatment. Through Komen's National Vulnerable Populations Grants Program, Komen funds large-scale community grants that seek to improve quality of care, care coordination, and address unique barriers to breast care for disparate populations. Since the initiation of these grants in 2008, Komen has invested over $7 million in programs that aim to eliminate disparities in breast cancer mortality. The following are some examples of the projects funded in fiscal year 2012 through Komen's National Vulnerable Population Grants Program: Komen funded an initiative with four Consulates of Mexico in the United States to integrate breast health materials and education into their Ventanillas de Salud (Window of Health) program (VDS program). The initiative involves a new pilot program that aims to eliminate disparities in breast cancer mortality among Mexican, Mexican-American and Hispanic women in the U.S. As a part of this new initiative, Komen awarded a total of $200,000 to four separate fiscal agencies that partner with Mexican Consulates to operate each local VDS program. The initial phase of the initiative will help build organizational capacity in four select markets to address key breast health barriers that are unique to Latino populations. The initiative not only integrates breast health materials into the VDS program, but also increases the program's reach into the community. Komen also awarded a $500,000 grant to the American Association on Health and Disability to fund Project Accessibility USA: Removing Barriers for Women with Disabilities. The goal of the project is to work towards reducing breast cancer health disparities in women with disabilities by improving accessibility of screening sites; providing site specific recommendations to providers on strategies to ensure accessibility for women with disabilities; developing a web-based Resource Learning Center; and developing educational training modules on disability culture and sensitivity for healthcare professionals. Komen awarded $225,000 to the National Cancer Institute to sponsor the California Health Interview Survey (CHIS) breast cancer control data collection. CHIS is the largest and most comprehensive state health survey in the United States. CHIS provides the only robust breast cancer screening estimates for Asian Americans nationalities in the U.S. As no Asian women were interviewed about mammography in an Asian language in 2011, funding from Komen will allow Asian respondents to be interviewed during 2012, thereby capturing critical information to inform future research and programs to improve breast health for Asian Americans. Komen awarded $134,552 to Eastern Michigan University Foundation to fund the Healthy Asians American Project. This project will increase breast health awareness and access through trained lay health advisors in underserved areas throughout China and Taiwan. D - Treatment Countless numbers of patients delay or forgo breast cancer treatment each year, and as a result, these women are less likely to survive. For this reason, Komen supports programs that connect people with local resources, psychosocial support, and provide critical financial assistance. In 2012, Komen awarded a $500,000 grant to CancerCare to support the Linking A.R.M.S.TM (Assistance & Resources Made Simple) program. Linking A.R.M.S.TM is a program dedicated to providing financial assistance, education and support services to low-income, under- or uninsured breast cancer survivors. Funding for Linking A.R.M.S.TM provides direct financial assistance to approximately 1,336 breast cancer survivors for treatment-related expenses including pain and anti-nausea medication, lymphedema care, oral chemotherapy, durable medical equipment, childcare, and transportation to and from treatment. CancerCare also provides counseling and other support services that enable breast cancer patients to make informed treatment decisions, cope with the emotional effects of the disease, and experience an improved quality of life. In addition, Komen awarded a $1,500,000 grant to the Patient Advocate Foundation, a national non-profit organization that handles medical debt crisis management, for its Co-Pay Relief (CPR) program. The CPR program was launched in April 2004, providing direct financial assistance for pharmaceutical co-payments to patients with breast cancer, lung cancer and prostate cancer. Komen's funding, along with that of other key partners, will touch more than 10,000 breast cancer patients served through the program over the next two years. All told, Komen and its Affiliates have committed more than $1.8 billion to community programs since 1982, and in fiscal year 2012 partnered with almost 2,000 organizations to provide education, screening, treatment support and psychosocial programs. For more information about any of the accomplishments described here or to learn more about Susan G. Komen for the Cure, visit www.komen.org or call 1-877 GO KOMEN (1-877-465-6636). Description of Relationships Form 990, Part VI, Question 2 Eric Brinker, Board Member, is the son of Nancy G. Brinker, CEO and Board member. Describe the Process used by Management &/or Governing Body to Review 990 Form 990, Part VI, Question 11b Management prepares the materials for the Form 990, with the assistance and review by external accountants. Senior levels of management review and comment on the final draft of the Form 990 for presentation to the audit committee of the board of directors. The audit committee of the Board of the Directors reviews and approves the Form 990 prior to being filed. Thereafter, each member of the Board of Directors receives an electronic copy of the Form 990 via email prior to the form being filed. Description of Process to Monitor Transactions for Conflicts of Interest Form 990, Part VI, Question 12c The organization produces an annual survey requiring all employees, board members, committee members and advisory boards to inform on conflicts. Any conflicts are then reviewed by management and the audit committee and appropriate measures are taken. In addition, those same people have the obligation to update the conflict of interest statements during the year. Offices & Positions for Which Process was Used, & Year Process was Begun Form 990, Part VI, Question 15a and 15b The Compensation Committee of the Board of Directors assists the Board of Susan G. Komen for the Cure in overseeing compensation policies and practices. Responsibilities include oversight of the compensation of the President/ Chief Executive Officer, the range of compensation levels for the organization's other officers, disqualified persons, and other employees, granting the CEO authority to determine actual compensation levels within an approved range, and incentive/bonus compensation programs. The current policy was adopted in 2010. A formal Compensation Policy governs pay practices. Periodically, all positions in the organization are reviewed against external market data, engaging independent experts to conduct the benchmarking process. Compensation is then based upon comparable market rates of pay with consideration for internal equity and the financial position of the organization. For the CEO and officers of the organization, external benchmarking was conducted again this fiscal year to ensure market alignment. Salary increases, promotions or other forms of compensation are provided without regard to race, color, religion, gender, national origin, disability, veteran status or sexual orientation. Avail of Gov Docs, Conflict of Interest Policy, & Fin Stmts to Gen Public Form 990, Part VI, Question 19 The Organization's financial statements, conflict of interest policy and the 990 are publicly available on our website. The Articles of Incorporation are available from the Texas Secretary of State and other governing documents are made available as required by state law. Form 1023 is not online but available to the public upon request. ADDITIONAL DETAIL ON RACE PRODUCTION EXPENSES INCLUDED ON OTHER EXP LINE Form 990, Part IX, Line 24 THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. PURCHASES ALL T-SHIRTS FOR THE 133 RACES HELD BY THE KOMEN AFFILIATES DURING THE YEAR. Reconciliation of Net Assets Part XI, Line 5 Unrealized losses on investments = ($3,580,874) In Kind services Revenues = $13,250,636 In Kind services expenses = ($14,060,197) Rescinded Grants = $1,734,535 ----------- Total ($2,655,900)